Dr Reddy’s Laboratories has started withdrawing its muscle relaxant –
tizanidine tablets, from the US market because of labeling issues. The
entity has taken this decision after receiving the notification issued
by United States Food and Drug Administration (FDA), and the same was
intimated to the drug regulator through a letter on March 19.Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.
No comments:
Post a Comment